Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|August 7, 2018
Transgenic Mouse Models in Cancer ResearchUrsa Lampreht Tratar, Simon Horvat, Maja Cemazar
Cancer Immunology, Immunotherapy : CII|February 23, 2018
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma modelUrska Kamensek, Maja Cemazar, Ursa Lampreht Tratar, et al.
Frontiers in Veterinary Science|May 15, 2026
The use of a bipolar single-needle electrode for electrochemotherapy combined with gene electrotransfer of IL-12 in a mast cell tumor on the nasal planum of a dog: case reportUrsa Lampreht Tratar, Tanja Svara, Maja Cemazar, et al.
Veterinary Medicine and Science|January 8, 2020
Health-related quality of life in dogs treated with electrochemotherapy and/or interleukin-12 gene electrotransferNina Milevoj, Natasa Tozon, Sabina Licen, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and CatsNatasa Tozon, Ursa Lampreht Tratar, Katarina Znidar, et al.
Cancers|January 10, 2026
Effect of Bleomycin Hydrolase Expression in Tumor Tissue on the Therapeutic Effectiveness of ElectrochemotherapyJan Bogataj, Ursa Lampreht Tratar, Gregor Sersa, et al.
Cancer Gene Therapy|March 30, 2018
Antitumor effect of antibiotic resistance gene-free plasmids encoding interleukin-12 in canine melanoma modelUrsa Lampreht Tratar, Spela Kos, Urska Kamensek, et al.
Mediators of Inflammation|June 10, 2017
Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine MelanomaUrsa Lampreht Tratar, Luisa Loiacono, Maja Cemazar, et al.
Frontiers in Immunology|September 22, 2022
Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune responseTinkara Remic, Gregor Sersa, Kristina Levpuscek, et al.
Cancers|January 10, 2026
Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune ProfilesMasa Omerzel, Simona Kranjc Brezar, Ursa Lampreht Tratar, et al.
Pageof 3